Cargando…

HDL as a Biomarker, Potential Therapeutic Target, and Therapy

Detalles Bibliográficos
Autores principales:	Navab, Mohamad, Anantharamaiah, G.M., Reddy, Srinivasa T., Van Lenten, Brian J., Fogelman, Alan M.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780869/ https://www.ncbi.nlm.nih.gov/pubmed/19940234 http://dx.doi.org/10.2337/db09-0538

Ejemplares similares

Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity
por: Kelesidis, Theodoros, et al.
Publicado: (2012)

HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL
por: Kelesidis, Theodoros, et al.
Publicado: (2011)

Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice
por: Su, Feng, et al.
Publicado: (2020)

Nutrient-Sensing Mechanisms in the Gut as Therapeutic Targets for Diabetes
por: Breen, Danna M., et al.
Publicado: (2013)

Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes
por: Morgantini, Cecilia, et al.
Publicado: (2010)

Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer
por: Chattopadhyay, Arnab, et al.
Publicado: (2015)

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
por: Ito, Fumiaki, et al.
Publicado: (2020)

Immunomodulation by Mesenchymal Stem Cells : A Potential Therapeutic Strategy for Type 1 Diabetes
por: Abdi, Reza, et al.
Publicado: (2008)

Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
por: Finck, Brian N.
Publicado: (2018)

Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes
por: Morgantini, Cecilia, et al.
Publicado: (2011)

Oral Apolipoprotein A‐I Mimetic D‐4F Lowers HDL‐Inflammatory Index in High‐Risk Patients: A First‐in‐Human Multiple‐Dose, Randomized Controlled Trial
por: Dunbar, Richard L., et al.
Publicado: (2017)

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015)

New Insights Into Gestational Glucose Metabolism: Lessons Learned From 21st Century Approaches
por: Angueira, Anthony R., et al.
Publicado: (2015)

Diabetic Retinopathy: Targeting Vasoregression
por: Hammes, Hans-Peter, et al.
Publicado: (2011)

Targeting FXR and FGF19 to Treat Metabolic Diseases—Lessons Learned From Bariatric Surgery
por: Bozadjieva, Nadejda, et al.
Publicado: (2018)

Protein Kinase C Function in Muscle, Liver, and β-Cells and Its Therapeutic Implications for Type 2 Diabetes
por: Schmitz-Peiffer, Carsten, et al.
Publicado: (2008)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
por: Wahren, John, et al.
Publicado: (2012)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

The Paradox of Progress: Environmental Disruption of Metabolism and the Diabetes Epidemic
por: Neel, Brian A., et al.
Publicado: (2011)

Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls
por: Drucker, Daniel J.
Publicado: (2013)

AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
por: Hardie, D. Grahame
Publicado: (2013)

HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic
por: Morin, Emily E., et al.
Publicado: (2018)

Using the Past to Inform the Future: Anti-VEGF Therapy as a Road Map to Develop Novel Therapies for Diabetic Retinopathy
por: Titchenell, Paul M., et al.
Publicado: (2013)

FBXO45 is a potential therapeutic target for cancer therapy
por: Lin, Min, et al.
Publicado: (2020)

Metformin Pharmacogenomics: Current Status and Future Directions
por: Pawlyk, Aaron C., et al.
Publicado: (2014)

Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice
por: Ishikawa, Kazunobu, et al.
Publicado: (2012)

Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes
por: Petrelli, Alessandra, et al.
Publicado: (2021)

Dysfunction of axonal transport in normal-tension glaucoma: a biomarker of disease progression and a potential therapeutic target
por: Hirooka, Kazuyuki, et al.
Publicado: (2020)

Microparticles as Novel Biomarkers and Therapeutic Targets in Coronary Heart Disease
por: Zhou, Bo-Da, et al.
Publicado: (2015)

HDL and LDL: Potential New Players in Breast Cancer Development
por: Cedó, Lídia, et al.
Publicado: (2019)

COVID-19–Induced New-Onset Diabetes: Trends and Technologies
por: Metwally, Ahmed A., et al.
Publicado: (2021)

Antigen-Based Therapy for the Treatment of Type 1 Diabetes
por: Tian, Jide, et al.
Publicado: (2009)

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
por: Linsley, Peter S., et al.
Publicado: (2021)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Chernick, Dustin, et al.
Publicado: (2020)

It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014)

cGMP signaling: a potential therapeutic target for neurodegeneration in glaucoma?
por: Holden, Joseph M., et al.
Publicado: (2022)

Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?
por: O’Kell, Allison L., et al.
Publicado: (2017)

From Pancreatic β-Cell Gene Networks to Novel Therapies for Type 1 Diabetes
por: Eizirik, Decio L., et al.
Publicado: (2021)

American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome
por: Semenkovich, Clay F., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h9q458blv6vsvjlf06b7j0n3t1